Key facts
- This page summarizes Hong Yu's Form 4 filing for Biostage, Inc. (HRGN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Dec 2022, 16:21.
Hong Yu - 07 Dec 2022 Form 4 Insider Report for Biostage, Inc. (HRGN)
- Reporting relationship
- PRESIDENT
- Issuer ticker
- HRGN
- Reported as of
- 07 Dec 2022
- Net transaction value
- +$43.08
- SEC form
- 4
- Accepted by SEC
- 09 Dec 2022, 16:21:07 UTC
- Prior SEC filing
- 20 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Chad Porter, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Hong Yu filed Form 4 for Biostage, Inc. (HRGN) on 09 Dec 2022.
Change
- Previous filing in this sequence was filed on 20 May 2022.
- Current net transaction value: +$43.08.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSTG
transaction
Common Stock
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $600,000
- Shares
- +300,000
- Change %
- +4890%
- Price
- $2.00
- Shares after
- 306,135
- Date
- 07 Dec 2022
- Ownership
- The spouse of the reporting person
BSTG
transaction
Common Stock
Sale
- Transaction value
- $599,957
- Shares
- -83,676
- Change %
- -27%
- Price
- $7.17
- Shares after
- 222,459
- Date
- 07 Dec 2022
- Ownership
- The spouse of the reporting person
- Footnotes
- F1
BSTG
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 44,520
- Date
- 07 Dec 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BSTG
transaction
Derivative
Warrants (right to buy)
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $0
- Shares
- -300,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 07 Dec 2022
- Ownership
- The spouse of the reporting person
- Underlying class
- Common Stock
- Underlying amount
- 300,000
- Exercise price
- $2.00
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On December 7, 2022, the Spouse of the Reporting Person exercised a warrant to purchase 300,000 shares of common stock for $2 per share. The Spouse of the Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 83,676 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 216,324 shares of common stock.